Background
The management of complex orthopedic infections usually includes a
prolonged course of intravenous antibiotic agents. We investigated whether
oral antibiotic therapy is noninferior to intravenous antibiotic therapy for
this indication.
Methods
We enrolled adults who were being treated for bone or joint infection
at 26 U.K. centers. Within 7 days after surgery (or, if the infection was
being managed without surgery, within 7 days after the start of antibiotic
treatment), participants were randomly assigned to receive either
intravenous or oral antibiotics to complete the first 6 weeks of therapy.
Follow-on oral antibiotics were permitted in both groups. The primary end
point was definitive treatment failure within 1 year after randomization. In
the analysis of the risk of the primary end point, the noninferiority margin
was 7.5 percentage points.
Results
Among the 1054 participants (527 in each group), end-point data were
available for 1015 (96.3%). Treatment failure occurred in 74 of 506
participants (14.6%) in the intravenous group and 67 of 509 participants
(13.2%) in the oral group. Missing end-point data (39 participants, 3.7%)
were imputed. The intention-to-treat analysis showed a difference in the
risk of definitive treatment failure (oral group vs. intravenous group) of
−1.4 percentage points (90% confidence interval [CI], −4.9 to
2.2; 95% CI, −5.6 to 2.9), indicating noninferiority. Complete-case,
per-protocol, and sensitivity analyses supported this result. The
between-group difference in the incidence of serious adverse events was not
significant (146 of 527 participants [27.7%] in the intravenous group and
138 of 527 [26.2%] in the oral group; P = 0.58). Catheter complications,
analyzed as a secondary end point, were more common in the intravenous group
(9.4% vs. 1.0%).
Conclusions
Oral antibiotic therapy was noninferior to intravenous antibiotic
therapy when used during the first 6 weeks for complex orthopedic infection,
as assessed by treatment failure at 1 year. (Funded by the National
Institute for Health Research; OVIVA Current Controlled Trials number,
ISRCTN91566927.)
ObjectivesWe describe treatment failure rates by antibiotic duration for prosthetic joint infection (PJI) managed with debridement, antibiotics and implant retention (DAIR).MethodsWe retrospectively collected data from all the cases of PJI that were managed with DAIR over a 5 year period. Surgical debridement, microbiological sampling, early intravenous antibiotics and prolonged oral follow-on antibiotics were used.ResultsOne hundred and twelve cases of PJI were identified. Twenty infections (18%) recurred during a mean follow-up of 2.3 years. The mean duration of antibiotic use was 1.5 years. Failure was more common after arthroscopic debridement, for previously revised joints and for Staphylococcus aureus infection. There were 12 failures after stopping antibiotics and 8 while on antibiotics [hazard ratio (HR) = 4.3, 95% confidence interval (CI) 1.4–12.8, P = 0.01]. However, during the first 3 months of follow-up, there were eight failures after stopping antibiotics and two while on antibiotics (HR = 7.0, 95% CI 1.5–33, P = 0.015). The duration of antibiotic therapy prior to stopping did not predict outcome.ConclusionsPJI may be managed by DAIR. The risk of failure with this strategy rises after stopping oral antibiotics, but lengthening antibiotic therapy may simply postpone, rather than prevent, failure.
Prostatitis is characterized by voiding symptoms and genitourinary pain and is sometimes associated with sexual dysfunction. Up to 25% of men receive a diagnosis of prostatitis in their lifetime, but <10% have a proven bacterial infection. The causes and treatment of nonbacterial prostatitis are largely unknown, but bacterial prostatitis is caused by infection with uropathogens, especially gram-negative bacilli, although infection is sometimes due to gram-positive and atypical microorganisms. Acute bacterial prostatitis is easily diagnosed (by abrupt urogential and often systemic symptoms, along with bacteriuria) and treated (by systemic antibiotic therapy). Chronic bacterial prostatitis is characterized by prolonged or recurrent symptoms and relapsing bacteriuria; diagnosis traditionally requires comparing urinary specimens obtained before with specimens obtained after prostatic massage. Treating chronic bacterial prostatitis requires prolonged therapy with an antibiotic that penetrates the prostate (ie, one with high lipid solubility, a low degree of ionization, high dissociation constant, low protein binding, and small molecular size). We review recent pharmacological and clinical data on treating bacterial prostatitis.
Objective: We report cases of central or atypical skull base osteomyelitis and review issues related to the diagnosis and treatment. Methods: The four cases presented, which were drawn from the Oxford, United Kingdom, skull base pathology database, had a diagnosis of central skull base osteomyelitis. Results: Four cases are presented in which central skull base osteomyelitis was diagnosed. Contrary to malignant otitis externa, our cases were not preceded by immediate external infections and had normal external ear examinations. They presented with headache and a variety of cranial neuropathies. Imaging demonstrated bone destruction, and subsequent microbiological analysis diagnosed infection and prompted prolonged antibiotic treatment. Conclusion: We concluded that in the diabetic or immunocompromised patient, a scenario of headache, cranial neuropathy, and bony destruction on imaging should raise the possibility of skull base osteomyelitis, even in the absence of an obvious infective source. The primary goal should still be to exclude an underlying malignant cause.
ObjectivesWe describe rates of success for two-stage revision of prosthetic joint infection (PJI), including data on reimplantation microbiology.MethodsWe retrospectively collected data from all the cases of PJI that were managed with two-stage revision over a 4 year period. Patients were managed with an antibiotic-free period before reimplantation, in order to confirm, clinically and microbiologically, that infection was successfully treated.ResultsOne hundred and fifty-two cases were identified. The overall success rate (i.e. retention of the prosthesis over 5.75 years of follow-up) was 83%, but was 89% for first revisions and 73% for re-revisions [hazard ratio = 2.9, 95% confidence interval (CI) 1.2–7.4, P = 0.023]. Reimplantation microbiology was frequently positive (14%), but did not predict outcome (hazard ratio = 1.3, 95% CI 0.4–3.7, P = 0.6). Furthermore, most unplanned debridements following the first stage were carried out before antibiotics were stopped (25 versus 2 debridements).ConclusionsWe did not identify evidence supporting the use of an antibiotic-free period before reimplantation and routine reimplantation microbiology. Re-revision was associated with a significantly worse outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.